MDL | MFCD14744412 |
---|---|
Molecular Weight | 380.44 |
Molecular Formula | C21H24N4O3 |
SMILES | O=C(NC1=C(N2CCCC2)C=C(N3C)C(N(C)C3=O)=C1)C4=CC=CC=C4OC |
IC50: 3.517 μM (BRPF2), >10 μM (BRD4 (1)), 0.172 μM (BRPF1B), >10 μM (TRIM24) [1] .
PFI-4 (1.25 µM; 7 or 11 days) inhibits differentiation of human osteoclasts [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Viability Assay [1]
Cell Line: | Osteoclasts |
Concentration: | 1.25 µM |
Incubation Time: | 7 or 11 days |
Result: | Significantly reduces MMP9 secretion in osteoclasts. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 26 mg/mL ( 68.34 mM ; Need ultrasonic and warming)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.6285 mL | 13.1427 mL | 26.2854 mL |
5 mM | 0.5257 mL | 2.6285 mL | 5.2571 mL |
10 mM | 0.2629 mL | 1.3143 mL | 2.6285 mL |